• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implementation of the malaria candidate vaccine RTS,S/AS01.

作者信息

Greenwood Brian, Doumbo Ogobara K

机构信息

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Malaria Research and Training Centre, University of Bamako, Bamako, Mali.

出版信息

Lancet. 2016 Jan 23;387(10016):318-319. doi: 10.1016/S0140-6736(15)00807-7. Epub 2015 Nov 6.

DOI:10.1016/S0140-6736(15)00807-7
PMID:26549465
Abstract
摘要

相似文献

1
Implementation of the malaria candidate vaccine RTS,S/AS01.疟疾候选疫苗RTS,S/AS01的实施
Lancet. 2016 Jan 23;387(10016):318-319. doi: 10.1016/S0140-6736(15)00807-7. Epub 2015 Nov 6.
2
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.RTS,S/AS01疟疾疫苗的公共卫生影响及成本效益：四种数学模型预测结果的系统比较
Lancet. 2016 Jan 23;387(10016):367-375. doi: 10.1016/S0140-6736(15)00725-4. Epub 2015 Nov 6.
3
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.RTS,S/AS01E 候选疟疾疫苗与扩大免疫规划疫苗联合接种的安全性和有效性：一项随机、开放标签、2 期临床试验的 19 个月随访。
Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.
4
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.非洲疟疾流行国家中疟疾疫苗RTS,S/AS01成本效益的具体预测。
Vaccine. 2017 Jan 3;35(1):53-60. doi: 10.1016/j.vaccine.2016.11.042. Epub 2016 Nov 24.
5
The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.RTS,S/AS01疟疾疫苗的未来：一项替代发展计划。
PLoS Med. 2016 Apr 12;13(4):e1001994. doi: 10.1371/journal.pmed.1001994. eCollection 2016 Apr.
6
RTS,S/AS01 malaria vaccine and child mortality.RTS,S/AS01疟疾疫苗与儿童死亡率
Lancet. 2015 Oct 31;386(10005):1736. doi: 10.1016/S0140-6736(15)00694-7.
7
Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.RTS,S/AS疟疾疫苗的临床开发：对I-III期临床试验的系统评价
Future Microbiol. 2015;10(10):1553-78. doi: 10.2217/fmb.15.90. Epub 2015 Oct 6.
8
Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: a randomized, double-blind, lot-to-lot consistency trial.候选RTS,S/AS01疫苗在尼日利亚幼儿中的免疫原性和安全性：一项随机、双盲、批次间一致性试验。
Vaccine. 2014 Nov 12;32(48):6556-62. doi: 10.1016/j.vaccine.2014.07.067. Epub 2014 Jul 28.
9
Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.三期 RTS, S/AS01 疟疾疫苗试验的疗效：需要替代的研发计划。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2098-2101. doi: 10.1080/21645515.2017.1295906. Epub 2017 Mar 8.
10
RTS,S/AS01 malaria vaccine in African children.RTS,S/AS01疟疾疫苗用于非洲儿童。
N Engl J Med. 2012 Feb 23;366(8):765. doi: 10.1056/NEJMc1200170.

引用本文的文献

1
Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions.疟疾疫苗与全球公平性：当前进展与未来方向的范围综述
Biomedicines. 2025 May 22;13(6):1270. doi: 10.3390/biomedicines13061270.
2
Community awareness, knowledge and perception about malaria vaccine in the Kassena-Nankana East Municipality: A descriptive cross-sectional survey.卡塞纳-南卡纳东地区社区对疟疾疫苗的认知、知识和看法：一项描述性的横断面调查。
Nurs Open. 2024 Sep;11(9):e70025. doi: 10.1002/nop2.70025.
3
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.
临床试验中结核病疫苗的最新进展和基于病毒样颗粒的疫苗候选物。
Front Immunol. 2023 Nov 2;14:1238649. doi: 10.3389/fimmu.2023.1238649. eCollection 2023.
4
Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying Antigen Ag85B Enhance Ag85B-Specific Immune Responses in Female C57BL/c Mice.纳米大小的嵌合人乳头瘤病毒 16 L1 病毒样颗粒展示抗原 Ag85B，增强雌性 C57BL/c 小鼠中 Ag85B 特异性免疫应答。
Viruses. 2023 Oct 19;15(10):2123. doi: 10.3390/v15102123.
5
Trained immunity: a cutting edge approach for designing novel vaccines against parasitic diseases?训练免疫：设计新型寄生虫病疫苗的前沿方法？
Front Immunol. 2023 Oct 6;14:1252554. doi: 10.3389/fimmu.2023.1252554. eCollection 2023.
6
A protocol for systematic review and meta-analysis of optimizing treatment for malaria.一项关于优化疟疾治疗的系统评价与荟萃分析方案。
Medicine (Baltimore). 2020 Sep 4;99(36):e22044. doi: 10.1097/MD.0000000000022044.
7
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.疟疾传播阻断疫苗靶向 Pfs230 和 Pfs230-Pfs48/45 蛋白的结构与功能。
Commun Biol. 2020 Jul 24;3(1):395. doi: 10.1038/s42003-020-01123-9.
8
Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming.腺相关病毒作为腺病毒初免后的有效疟疾增强疫苗。
Front Immunol. 2019 Apr 5;10:730. doi: 10.3389/fimmu.2019.00730. eCollection 2019.
9
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.中和抗体在恶性疟原虫入侵人红细胞的过程中阻断 Rh5/Ripr/CyRPA 复合物的功能。
Cell Microbiol. 2019 Jul;21(7):e13030. doi: 10.1111/cmi.13030. Epub 2019 Apr 24.
10
Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.表达疟疾抗原的重组麻疹疫苗可诱导小鼠产生长期记忆并提供保护。
NPJ Vaccines. 2019 Feb 27;4:12. doi: 10.1038/s41541-019-0106-8. eCollection 2019.